Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Cash & Equivalents (2016 - 2025)

Scynexis' Cash & Equivalents history spans 13 years, with the latest figure at $21.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 32.45% year-over-year to $21.3 million; the TTM value through Dec 2025 reached $21.3 million, up 32.45%, while the annual FY2025 figure was $21.3 million, 32.45% up from the prior year.
  • Cash & Equivalents reached $21.3 million in Q4 2025 per SCYX's latest filing, down from $37.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $118.7 million in Q2 2022 to a low of $6.9 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $69.3 million, with a median of $87.8 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 354.31% in 2021, then plummeted 92.63% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $104.5 million in 2021, then plummeted by 56.15% to $45.8 million in 2022, then dropped by 25.68% to $34.0 million in 2023, then crashed by 52.86% to $16.1 million in 2024, then surged by 32.45% to $21.3 million in 2025.
  • Per Business Quant, the three most recent readings for SCYX's Cash & Equivalents are $21.3 million (Q4 2025), $37.9 million (Q3 2025), and $46.5 million (Q2 2025).